Ashton Coetzee

Ashton Coetzee

Auto-generated profile, based on publicly available information

Ashton Coetzee

Department of Paediatrics, Paediatric Nephrology Division, University of Cape Town, Cape Town, South Africa

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
MMMignon I. McCulloch
Mignon I. McCulloch
VLValerie A. Luyckx
Valerie A. Luyckx
BMBrenda Morrow
Brenda Morrow
PNPeter Nourse
Peter Nourse
ACAshton Coetzee
Ashton Coetzee
AAAndrew C. Argent
Andrew C. Argent
Background: Dialysis is lifesaving for acute kidney injury (AKI), but access is poor in less resourced settings. A “peritoneal dialysis (PD) first” policy for paediatric AKI is more feasible than haemodialysis in low-resource settings. Methods: Retrospective review of modalities and outcomes of children dialysed acutely at Red Cross War Memorial Children’s Hospital between 1998 and 2020. Results: Of the 593 children with AKI who received dialysis, 463 (78.1%) received PD first. Median age was 9.0 (range 0.03–219.3; IQR 13.0–69.6) months; 57.6% were < 1 year old. Weights ranged from 0.9 to 2.0 kg (median 7.0 kg, IQR 3.0–16.0 kg); 38.6% were < 5 kg. PD was used more in younger children compared to extracorporeal dialysis (ECD), with median ages 6.4 (IQR 0.9–30.4) vs. 73.9 (IQR 17.5–113.9) months, respectively (p = 0.001). PD was performed with Seldinger soft catheters (n = 480/578, 83%), predominantly inserted by paediatricians at the bedside (n = 412/490, 84.1%). Complications occurred in 99/560 (17.7%) children receiving PD. Overall, 314/542 (57.8%) children survived. Survival was significantly lower in neonates (< 1 month old, 47.5%) and infants (1–12 months old, 49.2%) compared with older children (> 1 year old, 70.4%, p < 0.0001). Survival was superior in the ECD (75.4%) than in the PD group (55.6%, p = 0.002). Conclusions: “PD First for Paediatric AKI” is a valuable therapeutic approach for children with AKI. It is feasible in low-resourced settings where bedside PD catheter insertion can be safely taught and is an acceptable dialysis modality, especially in settings where children with AKI would otherwise not survive. Graphical

29 March 2024 in Pediatric Transplantation
Verified
Journal Article
Open access
AAAdewale E. Adetunji
Adewale E. Adetunji
PGPriya Gajjar
Priya Gajjar
VLValerie A. Luyckx
Valerie A. Luyckx
DRDeveshni Reddy
Deveshni Reddy
NCNicolette Collison
Nicolette Collison
MMMignon I. McCulloch
Mignon I. McCulloch
Background: Kidney transplantation remains the treatment of choice for children with kidney failure (KF). In South Africa, kidney replacement therapy (KRT) is restricted to children eligible for transplantation. This study reports on the implementation of the Paediatric Feasibility Assessment for Transplantation (pFAT) tool, a psychosocial risk score developed in South Africa to support transparent transplant eligibility assessment in a low‐resource setting.Methods: Single‐center retrospective descriptive analysis of children assessed for KRT using pFAT tool from 2015 to 2021.Results: Using the pFAT form, 88 children (median [range] age 12.0 [1.1 to 19.0] years) were assessed for KRT. Thirty (34.1%) children were not listed for KRT, scoring poorly in all domains, and were referred for supportive palliative care. Fourteen of these 30 children (46.7%) died, with a median survival of 6 months without dialysis. Nine children were reassessed and two were subsequently listed. Residing >300 km from the hospital (p = .009) and having adherence concerns (p = .003) were independently associated with nonlisting. Of the 58 (65.9%) children listed for KRT, 40 (69.0%) were transplanted. One‐year patient and graft survival were 97.2% and 88.6%, respectively. Only one of the four grafts lost at 1‐year posttransplant was attributed to psychosocial issues.Conclusions: Short‐term outcomes among children listed using the pFAT form are good. Among those nonlisted, the pFAT highlights specific psychosocial/socioeconomic barriers, over which most children themselves have no power to change, which should be systemically addressed to permit eligibility of more children and save lives.

17 December 2024 in Pediatric Transplantation
Verified
Journal Article
Open access
ACAshton Coetzee
Ashton Coetzee
PNPeter Nourse
Peter Nourse
TATheresa Abdo
Theresa Abdo
TPTaryn Pienaar
Taryn Pienaar
TSThozama Siyothula
Thozama Siyothula
MMMignon I. McCulloch
Mignon I. McCulloch
Background: Blood group incompatibility previously represented an obstacle to living related donor (LRD) options; desensitization modalities have expanded LRD options. ABO‐incompatible kidney transplants have been successful in adults and pediatric liver transplants, but to date not yet in pediatric kidney transplants in South Africa.Case Report: Patient X is a 5 year old male with end‐stage kidney failure due to Posterior Urethral Valves, requiring peritoneal dialysis pre‐transplant. His sister was the only suitable LRD. The recipient was blood group A+; donor was blood group B+; HLA match was 5/10, nil HLA donor specific antibodies and negative CDC and Flow crossmatches. The recipients' anti‐B titer pre‐transplant was a maximum of 1:8. A pre‐emptive desensitization dose of Rituximab (375 mg/m2) was administered 4 weeks before transplant. The anti‐B titer decreased to 1:2 following the Rituximab (CD19% of 0%). Post‐transplant, the Anti‐B titers were monitored for the first 10 days, with a maximum titer of 1:8 (immunoadsorbtion therapy available if > 1:16, or if associated graft dysfunction). Immunosuppressant protocol consisted of Basiliximab, Tacrolimus, Azathioprine, and Prednisone. Post‐transplant, the creatinine improved to 60–70 μmol/L at Week 1. 7 weeks post‐transplant, serum creatinine increased > 10% with an antibody titer of 1:2. Kidney biopsy showed CNI‐related toxicity; renal function improved with reduction in Tacrolimus doses. Kidney function remains stable 1‐year post‐transplant with nil episodes of rejection.Conclusion: This is the first ABO‐incompatible kidney transplant in a pediatric patient in South Africa and represents an important step in expanding the pool of potential living related donors.

7 December 2025 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
DBDatonye Christopher Briggs
Datonye Christopher Briggs
KHKhanyisile Hlongwa
Khanyisile Hlongwa
MMMignon McCulloch
Mignon McCulloch
PNPeter Nourse
Peter Nourse
ABAnita Brink
Anita Brink
ACAshton Coetzee
Ashton Coetzee

29 November 2025 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
DBDatonye Christopher Briggs
Datonye Christopher Briggs
KHKhanyisile Hlongwa
Khanyisile Hlongwa
MMMignon McCulloch
Mignon McCulloch
PNPeter Nourse
Peter Nourse
ABAnita Brink
Anita Brink
ACAshton Coetzee
Ashton Coetzee
Introduction: Multicystic dysplastic kidney disease (MCDK) is a notable congenital anomaly of the kidney and urinary tract, with potential risk for chronic kidney disease, yet data from sub-Saharan Africa remain scarce. This study examined the pattern of MCDK, associated contralateral kidney abnormalities, determined the predictors of MCDK involution and assessed short-term outcomes in children followed beyond one year in South Africa. Method: This retrospective study involved children under 13 years of age with suspected unilateral MCDK, confirmed on kidney ultrasound and [ 99m Tc]Tc-MAG3 scans at the Red Cross War Memorial Children’s Hospital between January 1, 2014, and December 31, 2023. Demographic, clinical, and radiologic data were obtained. The Log-rank test and Cox Proportional Hazards regression analyses were used to identify predictors of MCDK involution. Results: Among 1,581 new cases, 98 (6.2%) had unilateral MCDK. 50% were male, and 57.1% had left-sided involvement. Median follow-up was 60 months (IQR: 12–72). Contralateral kidney abnormalities occurred in 17 (17.3%), most commonly duplex kidney (35.3%) and ureteropelvic junction obstruction (29.4%), but no vesicoureteric reflux was noted. Of 81 children followed beyond a year, 80.2% demonstrated contralateral hypertrophy, and 69.1% exhibited involution of the affected kidney. Initial kidney size ≤ 5.0 cm was the sole predictor of involution (Hazard Ratio: 2.42, 95% CI: 1.31–4.48). Urinary tract infections occurred in 18.5%, proteinuria in 2.5%, hypertension in 1.2%, and 2.5% developed chronic kidney disease related to contralateral dysplasia. One nephrectomy was performed, and no malignancies or deaths. At last follow-up, 28.4% were lost to follow-up, and 12.3% had transitioned to adolescent clinics. Conclusion: All MCDK cases were unilateral, with duplex kidney being the most common contralateral abnormality, a distinctive finding previously unreported. Follow-up into adolescence may be beneficial, as progression of chronic kidney disease is rare in those without contralateral anomalies. Multicentre long-term studies are needed to provide standardised follow-up guidelines.

28 July 2026 in Clinical Nuclear Medicine Open
Verified
Journal Article
Open access
KHKhanyisile Hlongwa
Khanyisile Hlongwa
AAAbdulsalam Al-Marrani
Abdulsalam Al-Marrani
SSShivani Singh
Shivani Singh
ACAshton Coetzee
Ashton Coetzee
SMStuart More
Stuart More
A 7-year-old boy with end-stage kidney disease secondary to posterior urethral valves underwent deceased donor renal transplantation complicated by suspected vascular thrombosis and delayed graft function. A [ 99m Tc]Tc-MAG3 renogram on day 2 post-transplant demonstrated absent perfusion and uptake, suggesting graft nonfunction, with no improvement on repeat imaging despite thrombectomy. However, [ 99m Tc]Tc-DMSA SPECT/CT demonstrated cortical tracer uptake within the graft, indicating residual viable renal tissue. Biopsy confirmed extensive necrosis with focal preserved glomeruli. The graft was deemed nonsalvageable and nephrectomy performed. This case highlights discordant functional and cortical imaging findings and underscores the value of multimodality imaging in complex renal transplant dysfunction.